[Retracted] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway

Liyan Du; Xiaomei Li; Linhong Zhen; Weiling Chen; Lingguang Mu; Yang Zhang; Ailin Song

Retracted

This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.

PMC · DOI:10.3892/mmr.2025.13508·March 31, 2025

[Retracted] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway

Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu, Yang Zhang, Ailin Song

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes2

MTOR AKT1

Proteins2

Chemicals1

Everolimus

Diseases1

breast cancer

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsRNA modifications and cancer